Department of Public Health, College of Medicine and Health Science, Injibara University, Injibara, Ethiopia.
Department of Pharmacy, College of Medicine and Health Science, Injibara University, Injibara, Ethiopia.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2208016. doi: 10.1080/21645515.2023.2208016.
The aim of this study is to assess COVID-19 vaccine uptake and associated factors among health science students at Wollo University, Northeast Ethiopia. Institution based cross-sectional study was conducted among 403 health science students at Wollo University from 1 to 15 July, 2022. The data was collected using a structured self-administered questionnaire and analysis was performed using SPSS version 26. Adjusted Odds Ratio (AOR), with 95% CI and p-value <.05 were used to declare factors significantly associated with COVID-19 vaccine uptake. The prevalence of COVID-19 vaccine uptake was 23.3% (95% CI: 19.2, 27.4). Being in the age category of 22-25 years old (AOR = 0.392, 95% CI (0.197, 0.780)), being >25 years old (AOR = 0.253, 95% CI (0.086, 0.741)), have a known disease (AOR = 0.202, 95% CI (0.044, 0.935)), source of income is self (AOR = 2.504, 95% CI (1.104, 5.677)) and screened for COVID-19 disease (AOR = 4.278, 95 % CI (2.418, 7.570)) before are significantly associated with uptake of COVID-19 vaccine. In conclusion, majority of the respondents didn't take COVID-19 vaccine with age greater than 22 years and have a known disease found to be negative predictors of COVID-19 disease.
本研究旨在评估埃塞俄比亚东北部沃尔洛大学卫生科学专业学生对 COVID-19 疫苗的接种情况及其相关因素。2022 年 7 月 1 日至 15 日,在沃尔洛大学对 403 名卫生科学专业学生进行了基于机构的横断面研究。使用结构化的自我管理问卷收集数据,并使用 SPSS 版本 26 进行分析。使用调整后的优势比(AOR)、95%置信区间(CI)和 p 值<.05 来表示与 COVID-19 疫苗接种显著相关的因素。COVID-19 疫苗接种的流行率为 23.3%(95%CI:19.2,27.4)。年龄在 22-25 岁(AOR=0.392,95%CI(0.197,0.780))、年龄大于 25 岁(AOR=0.253,95%CI(0.086,0.741))、患有已知疾病(AOR=0.202,95%CI(0.044,0.935))、收入来源为自己(AOR=2.504,95%CI(1.104,5.677))和在接种 COVID-19 疫苗之前对 COVID-19 疾病进行筛查(AOR=4.278,95%CI(2.418,7.570))与 COVID-19 疫苗接种显著相关。结论是,大多数受访者没有接种 COVID-19 疫苗,年龄大于 22 岁且患有已知疾病被发现是 COVID-19 疾病的负面预测因素。